Breast Cancer Survivorship
Cross-source consensus on Breast Cancer Survivorship from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Background
Evidence quality
Other
Highlighted claims
- Breast cancer is the most frequently diagnosed cancer and leading cause of cancer-related death among women worldwide. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- China had an estimated 357,000 new breast cancer cases in 2022. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- The study addresses limited prospective survivorship data from China despite persistent post-treatment symptoms among survivors. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Breast cancer care has expanded from cure alone to long-term survivorship because early detection and multimodal treatment have improved survival. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol
- Quality of life and survival are described as bidirectionally related in breast cancer survivorship. — PERSEVERE: longitudinal assessment of quality of life and treatment toxicities in Chinese breast cancer patients – a multicentre cohort study protocol